store at -20°C
Tocilizumab [375823-41-9]
Referência T9911-5mg
Tamanho : 5mg
Marca : TargetMol
Tocilizumab
Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the interleukin-6 receptor
Description | Tocilizumab (anti-IL-6R) is a humanized monoclonal antibody that binds to the interleukin-6 receptor |
Cell Research | Objective: To validate that IL-6 signaling is essential for TAM (tumor-associated macrophages)-enhanced CSC (cancer stem cells) function. Concentrations: 5 μg/ml. Incubation Time: 72 h. Method: For co-culture experiments, 12-well Transwell chambers were used with 2×105 HepG2 or Hep3B cells seeded in the lower chamber one day before co-culture and either 5×105 or 1×106 TAMs added in the upper chamber. Tocilizumab or human IgG antibody were added in indicated experiments to selected wells. After 24 to 72 hours, HCC cells and CD14+ TAM cells were collected separately for analysis. Cells:HepG2 cell lines, TAMs isolated from HCCs (hepatocellular carcinoma) |
Molecular Weight | 148 kDa |
CAS No. | 375823-41-9 |
Storage
References and Literature
Citations
Related Products
Dose Conversion
You can also refer to dose conversion for different animals. More
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Keywords
Tocilizumab 375823-41-9 Immunology/Inflammation Interleukin COVID-19 IL-6R Anti-Human IL6R, Humanized Antibody rheumatoid respiratory failure antibody Interleukin Related coronavirus disease arthritis inhibit dyspnoea Neutralizing Inhibitor inhibitor